Related Experiment Video
Updated: Jun 12, 2025

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Concentric remodeling and the metabolic-associated steatotic liver disease in patients with type 1 diabetes: an
Klaudia Czarnik1, Zbigniew Sablik2, Anna Borkowska3
1Department of Internal Diseases and Diabetology, Medical University of Lodz, Central Teaching Hospital in Lodz, 251 Pomorska Street, 92-213, Lodz, Poland. klaudia.czarnik@umed.lodz.pl.
Insights
In young patients with type 1 diabetes (T1D), a higher Fatty Liver Index (FLI) correlates with increased risk of left ventricle (LV) remodeling. This suggests FLI may help identify T1D patients needing closer cardiac monitoring.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Background:
- Diabetic cardiomyopathy in type 1 diabetes (T1D) often presents as asymptomatic diastolic dysfunction and left ventricle (LV) remodeling.
- The role of metabolic-associated steatotic liver disease (MASLD) in T1D-related cardiac remodeling is understudied.
- This research investigates the link between MASLD risk and LV remodeling in young T1D patients without heart failure.
Purpose of the Study:
- To determine the correlation between MASLD risk, assessed by Fatty Liver Index (FLI), and relative wall thickness (RWT) in young T1D patients.
- To explore the association between FLI and LV remodeling indicators in T1D.
- To identify potential predictors of cardiac remodeling in T1D.
Main Methods:
- Recruitment of T1D patients from an inpatient diabetology department.
- Collection of laboratory test results and echocardiographic data.
- Estimation of MASLD risk using FLI and statistical analysis of acquired data.
Main Results:
- The study included 55 T1D patients; 25 exhibited LV remodeling (RWT > 0.42).
- Patients with LV remodeling had significantly higher FLI (40.97 vs. 13.82) and BMI (27.3 vs. 22.5).
- FLI demonstrated a correlation with LV remodeling risk (OR 1.028, p=0.05), with an optimal predictive FLI cutoff of 26.38 for RWT > 0.42.
Conclusions:
- Fatty Liver Index (FLI) is correlated with relative wall thickness (RWT) in T1D patients.
- This association is independent of diabetes metabolic control.
- FLI may serve as a valuable tool for identifying T1D patients at higher risk for left ventricle remodeling.
Introduction:
Diabetic cardiomyopathy in young patients with type 1 diabetes (T1D) usually presents as asymptomatic diastolic heart dysfunction with left ventricle (LV) remodeling. Its prevalence seems to be underestimated. One of the factors seemingly influencing LV remodeling is a metabolic-associated steatotic liver disease (MASLD), which was extensively investigated in patients with type 2 diabetes but not with T1D. This study aimed to describe the correlation between MASLD risk and relative wall thickness (RWT) in young patients with T1D without heart failure symptoms or treatment.
Materials And Methods:
Study participants were recruited at the inpatient diabetology department, in admission order. Patients underwent a set of laboratory tests and echocardiographic examinations. The risk of MASLD was estimated using fatty liver index (FLI). Acquired data was then statistically analyzed.
Results:
The study group consisted of 55 patients. 25 participants had RWT > 0.42, suggesting LV remodeling. Study participants did not differ in HbA1c, NT-proBNP, HDL, LDL, non-HDL, and uric acid concentrations. However, patients with RWT > 0.42 had higher FLI (40.97 vs. 13.82, p < 0.01) and BMI (27.3 vs. 22.5, p < 0.01) and differed in transaminase concentrations. Moreover, patients with RWT > 0.42 had significantly higher LV mass index (85.6 vs. 68.2 g/m2) and altered mitral ring velocities. In univariable logistic regression, FLI correlated with LV remodeling risk (OR 1.028, p = 0.05). The optimal cutoff point for FLI predicting the RWT > 0.42 was 26.38 (OR 10.6, p = 0.04, sensitivity 0.857, specificity 0.657).
Conclusions:
FLI correlates with RWT in patients with T1D independently of diabetes metabolic control and hypothetically may support recognizing T1D patients with a higher risk of LV remodeling.
Related Concept Videos
Tissue Renewal without Stem Cells
However, failure of such a system...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational

